MSG
VRTX icon

Main Street Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Main Street Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4K Hold
25
– – ﹤0.01% 519
2026
Q1 		$11.2K Buy
+25
New +$11.7K ﹤0.01% 525
2025
Q4 		– Sell
-25
Closed -$9.79K – 607
2025
Q3 		$9.79K Hold
25
– – ﹤0.01% 513
2025
Q2 		$11.1K Hold
25
– – ﹤0.01% 472
2025
Q1 		$12.1K Hold
25
– – ﹤0.01% 474
2024
Q4 		$10.1K Hold
25
– – ﹤0.01% 489
2024
Q3 		$11.6K Hold
25
– – ﹤0.01% 475
2024
Q2 		$11.8K Hold
25
– – ﹤0.01% 495
2024
Q1 		$10.5K Hold
25
– – ﹤0.01% 532
2023
Q4 		$10.2K Buy
+25
New +$9.23K ﹤0.01% 798

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Main Street Group's VRTX Position: Q2 2026 in Review

Main Street Group held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 25 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #519.

Main Street Group first reported a position in VRTX in Q4 2023 and has held it in 10 quarters since. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Main Street Group held 25 shares of Vertex Pharmaceuticals worth $12.4K as of Q2 2026.
  • Main Street Group left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #519 holding.
  • Main Street Group first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.